首页> 外文期刊>Transplantation Proceedings >Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.
【24h】

Outcomes for hepatorenal syndrome and acute kidney injury in patients undergoing liver transplantation: a single-center experience.

机译:肝移植患者肝肾综合征和急性肾损伤的结果:单中心经验。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute kidney injury occurs commonly among patients with advanced liver disease. These patients may undergo liver transplantation with subsequent improvement in hepatic function. However, the renal outcomes of these patients after liver transplantation has only occasionally been reported. Knowledge of these outcomes would be useful to identify patients who may benefit from combined liver-renal transplantation. We retrospectively analyzed 29 patients who subsequently went on to have a liver transplantation. Seventeen of cases could be ascribed to hepatorenal syndrome (HRS) and 12 cases to ATN. Four patients with non-HRS and 12 patients with HRS required hemodialysis prior to transplantation. The duration of kidney injury prior to transplantation was 7.75 +/- 7.53 weeks in the HRS group and 5.09 +/- 4.47 weeks in the ATN group (P = NS). Demographic variables between patients with HRS and ATN were similar with the exception of a higher prevalence of diabetes among the ATN group (P < .05). At 3 months post-liver transplantation, 66% of patients with non-HRS and 77% of those surviving patients with HRS showed serum creatinine values less than 1.5 mg/dL. No patients remained on chronic hemodialysis at 3 months post-liver transplantation. The outcome of kidney dysfunction and more specifically, HRS, among those patients surviving to liver transplantation was excellent with subsequent resolution in the majority of patients. Determination of prognostic factors for renal outcome will require multicenter prospective trials, which would be useful to determine which patients benefit from combined liver-renal transplantation.
机译:急性肾脏损伤通常发生在晚期肝病患者中。这些患者可能接受肝移植,随后肝功能得到改善。但是,这些患者在肝移植后的肾结局只是偶尔报道。了解这些结局将有助于识别可能受益于肝肾联合移植的患者。我们回顾性分析了29例随后进行肝移植的患者。十七例可归因于肝肾综合征(HRS),十二例归因于ATN。 4例非HRS患者和12例HRS患者在移植前需要进行血液透析。 HRS组移植前的肾脏损伤持续时间为7.75 +/- 7.53周,而ATN组为5.09 +/- 4.47周(P = NS)。 HRS和ATN患者之间的人口统计学变量相似,但ATN组中糖尿病的患病率较高(P <.05)。肝移植后3个月,有66%的非HRS患者和77%的存活HRS患者的血清肌酐值低于1.5 mg / dL。肝移植后3个月没有患者继续进行慢性血液透析。在幸存肝移植的那些患者中,肾功能不全的结果,尤其是HRS的结果极佳,大多数患者随后得到了解决。确定肾预后的预后因素将需要进行多中心前瞻性试验,这将有助于确定哪些患者将从肝肾联合移植中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号